| Product sales | 1.07M |
| License fees | 60K |
| Commercial collaborations | |
| Contracts and grants | |
| Total revenues | 1.13M |
| Product | 1.21M |
| Commercial collaborations | |
| Contracts and grants | |
| Warranty and inventory reserves | |
| Total cost of goods sold | 1.21M |
| Gross (loss) profit | -74K |
| Research and development | 1.08M |
| Sales and marketing | 201K |
| General and administrative | 1.91M |
| Depreciation and amortization | 444K |
| Loss on disposal of assets | |
| Total operating expenses | 3.68M |
| Loss from operations | -3.76M |
| Interest expense | |
| Interest income | |
| Change in market value of warrants | |
| Gain/(loss) on foreign exchange | |
| Total other income, net | 12K |
| Loss from continuing operations | |
| Gain from discontinued operations | |
| Net loss | |
| Less: Net loss attributable to non-controlling interest | |
| Net loss attributable to Altair Nanotechnologies Inc. | -3.74M |
| Loss from continuing operations | |
| Gain from discontinued operations | |
| Net loss | |
| Loss from continuing operations (in Dollars per share) | |
| Loss per common share - basic and diluted (in Dollars per share) | -0.32 |
| Weighted average shares - basic and diluted (in Shares) | |